Click here to get full coverage on 70,000 patients' ketamine data may help FDA weigh suicide therapy - Stock Titan

70,000 patients' ketamine data may help FDA weigh suicide therapy  Stock Titan

70,000 patients' ketamine data may help FDA weigh suicide therapy - Stock Titan

Click here to get full coverage on NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - Yahoo Finance

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions  Yahoo Finance

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - Yahoo Finance

Click here to get full coverage on NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP - GuruFocus

NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP  GuruFocus

NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP - GuruFocus

Click here to get full coverage on NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - GlobeNewswire

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date  GlobeNewswire

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - GlobeNewswire

Click here to get full coverage on Why Did NRXP Stock Surge 21% Pre-Market Today? - Stocktwits

Why Did NRXP Stock Surge 21% Pre-Market Today?  Stocktwits

Why Did NRXP Stock Surge 21% Pre-Market Today? - Stocktwits

Click here to get full coverage on New Analyst Forecast: $NRXP Given $25 Price Target - Quiver Quantitative

New Analyst Forecast: $NRXP Given $25 Price Target  Quiver Quantitative

New Analyst Forecast: $NRXP Given $25 Price Target - Quiver Quantitative

Click here to get full coverage on NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Sahm

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval  Sahm

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Sahm

Click here to get full coverage on NRx Pharmaceuticals (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 - The Globe and Mail

NRx Pharmaceuticals (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100  The Globe and Mail

NRx Pharmaceuticals (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 - The Globe and Mail

Click here to get full coverage on NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Chartmill

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval  Chartmill

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Chartmill

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food and Drug Administration Seeking Removal of Benzethonium Chloride from Ketamine Products - PR Newswire

Click here to get full coverage on Shareholders face Jan. 26 deadline for NRx 2025 meeting proposals - Stock Titan

Shareholders face Jan. 26 deadline for NRx 2025 meeting proposals  Stock Titan

Shareholders face Jan. 26 deadline for NRx 2025 meeting proposals - Stock Titan

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression - PR Newswire

Click here to get full coverage on HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA) - PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA)  PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA) - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals Received Notice of Noncompliance - TradingView — Track All Markets

NRx Pharmaceuticals Received Notice of Noncompliance  TradingView — Track All Markets

NRx Pharmaceuticals Received Notice of Noncompliance - TradingView — Track All Markets

Click here to get full coverage on How Aruba used research to drive record tourism after the pandemic - Stock Titan

How Aruba used research to drive record tourism after the pandemic  Stock Titan

How Aruba used research to drive record tourism after the pandemic - Stock Titan

Click here to get full coverage on HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics - PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics  PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100) - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100) - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment - Yahoo Finance

NRx Pharmaceuticals (NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment  Yahoo Finance

NRx Pharmaceuticals (NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date - Yahoo Finance

NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date  Yahoo Finance

NRx Pharmaceuticals (NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals (NRXP) to Report Q3 2025 Financial Results and Host Conference Call on Nov. 17 - Yahoo Finance

NRx Pharmaceuticals (NRXP) to Report Q3 2025 Financial Results and Host Conference Call on Nov. 17  Yahoo Finance

NRx Pharmaceuticals (NRXP) to Report Q3 2025 Financial Results and Host Conference Call on Nov. 17 - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025 - Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025  Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025 - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Click here to get full coverage on BTIG Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq

BTIG Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation  Nasdaq

BTIG Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its Proprietary, Preservative Free Formulation of IV Ketamine - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third - GlobeNewswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third  GlobeNewswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third - GlobeNewswire

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - PR Newswire

Click here to get full coverage on HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions - PR Newswire

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions  PR Newswire

HOPE Therapeutics, Inc. a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Signing of Term Sheet for $7.8 Million Debt Financing to Fuel HOPE Clinic Acquisitions - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies - Yahoo Finance

NRx Pharmaceuticals (NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies  Yahoo Finance

NRx Pharmaceuticals (NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies - Yahoo Finance

Click here to get full coverage on HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics - PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics  PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals (NASDAQ:NRXP) Announce Signing of Definitive Agreement to Purchase Kadima Neuropsychiatry Institute; Foundational Acquisition for the HOPE Network of Interventional Psychiatry Clinics - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Strengthens Pipeline With Dual Pathways for Ketamine-Based Therapies - Yahoo Finance

NRx Pharmaceuticals (NRXP) Strengthens Pipeline With Dual Pathways for Ketamine-Based Therapies  Yahoo Finance

NRx Pharmaceuticals (NRXP) Strengthens Pipeline With Dual Pathways for Ketamine-Based Therapies - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs - Yahoo Finance

NRx Pharmaceuticals (NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs  Yahoo Finance

NRx Pharmaceuticals (NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update  Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals (NRXP) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference - Yahoo Finance

NRx Pharmaceuticals (NRXP) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference  Yahoo Finance

NRx Pharmaceuticals (NRXP) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product - Yahoo Finance

NRx Pharmaceuticals (NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product  Yahoo Finance

NRx Pharmaceuticals (NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th - Yahoo Finance

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th  Yahoo Finance

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th - Yahoo Finance

Click here to get full coverage on HC Wainwright & Co. Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq

HC Wainwright & Co. Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation  Nasdaq

HC Wainwright & Co. Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq

Click here to get full coverage on NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to - GlobeNewswire

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to  GlobeNewswire

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to - GlobeNewswire

Click here to get full coverage on Biotech wipes out final $5.4M debt as it pursues depression treatments - Stock Titan

Biotech wipes out final $5.4M debt as it pursues depression treatments  Stock Titan

Biotech wipes out final $5.4M debt as it pursues depression treatments - Stock Titan

Click here to get full coverage on NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call - GlobeNewswire

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call  GlobeNewswire

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call - GlobeNewswire

Click here to get full coverage on HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE - PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE  PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NRXP)’ NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression - Yahoo Finance

NRx Pharmaceuticals, Inc. (NRXP)’ NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression  Yahoo Finance

NRx Pharmaceuticals, Inc. (NRXP)’ NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression - Yahoo Finance

NRx Pharmaceuticals (NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression  Yahoo Finance

NRx Pharmaceuticals (NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM) - Yahoo Finance

NRx Pharmaceuticals (NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)  Yahoo Finance

NRx Pharmaceuticals (NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM) - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs - Yahoo Finance

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs  Yahoo Finance

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $NRXP Given $34.0 Price Target | NRXP Stock News - Quiver Quantitative

New Analyst Forecast: $NRXP Given $34.0 Price Target | NRXP Stock News  Quiver Quantitative

New Analyst Forecast: $NRXP Given $34.0 Price Target | NRXP Stock News - Quiver Quantitative

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference - Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference  Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NASDAQ: NRXP) Partners With neurocare Group AG To Build Nationwide Neuroplastic Care Network - The Globe and Mail

NRx Pharmaceuticals (NASDAQ: NRXP) Partners With neurocare Group AG To Build Nationwide Neuroplastic Care Network  The Globe and Mail

NRx Pharmaceuticals (NASDAQ: NRXP) Partners With neurocare Group AG To Build Nationwide Neuroplastic Care Network - The Globe and Mail

Click here to get full coverage on NRX Pharmaceuticals Inc (NRXP) Q2 2025 Earnings Report Preview: What to Expect - Yahoo Finance

NRX Pharmaceuticals Inc (NRXP) Q2 2025 Earnings Report Preview: What to Expect  Yahoo Finance

NRX Pharmaceuticals Inc (NRXP) Q2 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Click here to get full coverage on NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset - TechStock²

NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset  TechStock²

NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset - TechStock²

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical - Yahoo Finance

NRx Pharmaceuticals (NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical  Yahoo Finance

NRx Pharmaceuticals (NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025 - Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025  Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025 - Yahoo Finance

Click here to get full coverage on Ascendiant Capital Maintains NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq

Ascendiant Capital Maintains NRx Pharmaceuticals (NRXP) Buy Recommendation  Nasdaq

Ascendiant Capital Maintains NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq

Click here to get full coverage on NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - The Manila Times

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date  The Manila Times

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - The Manila Times

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression - PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression  PR Newswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market - Yahoo Finance

NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market  Yahoo Finance

NRx Pharmaceuticals (NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals ANDA for KETAFREE received by FDA | NRXP Stock News - Stock Titan

NRx Pharmaceuticals ANDA for KETAFREE received by FDA | NRXP Stock News  Stock Titan

NRx Pharmaceuticals ANDA for KETAFREE received by FDA | NRXP Stock News - Stock Titan

Click here to get full coverage on AI Stocks: Why is NRXP stock going down - Share Buyback & Real-Time Chart Pattern Alerts - baoquankhu1.vn

AI Stocks: Why is NRXP stock going down - Share Buyback & Real-Time Chart Pattern Alerts  baoquankhu1.vn

AI Stocks: Why is NRXP stock going down - Share Buyback & Real-Time Chart Pattern Alerts - baoquankhu1.vn

Click here to get full coverage on HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics - PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics  PR Newswire

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics - PR Newswire

Click here to get full coverage on NRx Pharmaceuticals (NRXP) Launches HOPE Therapeutics' One-Day TMS Protocol for Treatment-Resistant Depression in Florida - Yahoo Finance

NRx Pharmaceuticals (NRXP) Launches HOPE Therapeutics' One-Day TMS Protocol for Treatment-Resistant Depression in Florida  Yahoo Finance

NRx Pharmaceuticals (NRXP) Launches HOPE Therapeutics' One-Day TMS Protocol for Treatment-Resistant Depression in Florida - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative - Yahoo Finance

NRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative  Yahoo Finance

NRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative - Yahoo Finance

Click here to get full coverage on NRx Pharmaceuticals Addresses Nasdaq Meeting Compliance Requirements - TipRanks

NRx Pharmaceuticals Addresses Nasdaq Meeting Compliance Requirements  TipRanks

NRx Pharmaceuticals Addresses Nasdaq Meeting Compliance Requirements - TipRanks

Click here to get full coverage on Milestone Patient Data Eclipsing 70,000 on Real World Use - openPR.com

Milestone Patient Data Eclipsing 70,000 on Real World Use  openPR.com

Milestone Patient Data Eclipsing 70,000 on Real World Use - openPR.com

Click here to get full coverage on New Analyst Forecast: $NRXP Given $34 Price Target - Quiver Quantitative

New Analyst Forecast: $NRXP Given $34 Price Target  Quiver Quantitative

New Analyst Forecast: $NRXP Given $34 Price Target - Quiver Quantitative

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present - GlobeNewswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present  GlobeNewswire

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present - GlobeNewswire

Click here to get full coverage on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine) - Yahoo Finance

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)  Yahoo Finance

NRXP

Price Chart

Key Statistics

Technicals

About NRXP

Latest News

70,000 patients' ketamine data may help FDA weigh suicide therapy - Stock Titan

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - Yahoo Finance

NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP - GuruFocus

Advanced Charts

Top Gainers

Top Losers